HROW
Price
$36.19
Change
-$1.05 (-2.82%)
Updated
Jul 25 closing price
Capitalization
467.85M
16 days until earnings call
TLPH
Price
$0.42
Change
-$0.01 (-2.33%)
Updated
Jul 25 closing price
Capitalization
17.48M
Interact to see
Advertisement

HROW vs TLPH

Header iconHROW vs TLPH Comparison
Open Charts HROW vs TLPHBanner chart's image
Harrow
Price$36.19
Change-$1.05 (-2.82%)
Volume$325.48K
Capitalization467.85M
Talphera
Price$0.42
Change-$0.01 (-2.33%)
Volume$63.79K
Capitalization17.48M
HROW vs TLPH Comparison Chart in %
Loading...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HROW vs. TLPH commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROW is a Hold and TLPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (HROW: $36.19 vs. TLPH: $0.42)
Brand notoriety: HROW and TLPH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HROW: 77% vs. TLPH: 15%
Market capitalization -- HROW: $467.85M vs. TLPH: $17.48M
HROW [@Pharmaceuticals: Other] is valued at $467.85M. TLPH’s [@Pharmaceuticals: Other] market capitalization is $17.48M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HROW’s FA Score shows that 1 FA rating(s) are green whileTLPH’s FA Score has 0 green FA rating(s).

  • HROW’s FA Score: 1 green, 4 red.
  • TLPH’s FA Score: 0 green, 5 red.
According to our system of comparison, HROW is a better buy in the long-term than TLPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HROW’s TA Score shows that 4 TA indicator(s) are bullish while TLPH’s TA Score has 3 bullish TA indicator(s).

  • HROW’s TA Score: 4 bullish, 4 bearish.
  • TLPH’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, HROW is a better buy in the short-term than TLPH.

Price Growth

HROW (@Pharmaceuticals: Other) experienced а +0.84% price change this week, while TLPH (@Pharmaceuticals: Other) price change was +3.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

HROW is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HROW($468M) has a higher market cap than TLPH($17.5M). HROW YTD gains are higher at: 7.869 vs. TLPH (-19.271). HROW has higher annual earnings (EBITDA): 9.95M vs. TLPH (-9.84M). HROW has more cash in the bank: 82.8M vs. TLPH (9.38M). HROW has higher revenues than TLPH: HROW (130M) vs TLPH (651K).
HROWTLPHHROW / TLPH
Capitalization468M17.5M2,674%
EBITDA9.95M-9.84M-101%
Gain YTD7.869-19.271-41%
P/E Ratio39.53N/A-
Revenue130M651K19,969%
Total Cash82.8M9.38M883%
Total Debt191MN/A-
FUNDAMENTALS RATINGS
HROW vs TLPH: Fundamental Ratings
HROW
TLPH
OUTLOOK RATING
1..100
201
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
46100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
4188
P/E GROWTH RATING
1..100
11100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HROW's Valuation (79) in the Pharmaceuticals Other industry is in the same range as TLPH (96). This means that HROW’s stock grew similarly to TLPH’s over the last 12 months.

HROW's Profit vs Risk Rating (46) in the Pharmaceuticals Other industry is somewhat better than the same rating for TLPH (100). This means that HROW’s stock grew somewhat faster than TLPH’s over the last 12 months.

HROW's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as TLPH (98). This means that HROW’s stock grew similarly to TLPH’s over the last 12 months.

HROW's Price Growth Rating (41) in the Pharmaceuticals Other industry is somewhat better than the same rating for TLPH (88). This means that HROW’s stock grew somewhat faster than TLPH’s over the last 12 months.

HROW's P/E Growth Rating (11) in the Pharmaceuticals Other industry is significantly better than the same rating for TLPH (100). This means that HROW’s stock grew significantly faster than TLPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HROWTLPH
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 17 days ago
77%
Declines
ODDS (%)
Bearish Trend 20 days ago
81%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCVT5.904.05
+218.92%
Mill City Ventures III Ltd
WY26.470.79
+3.08%
Weyerhaeuser Company
NAK0.890.01
+1.69%
Northern Dynasty Minerals Ltd
TIGO40.40-0.28
-0.69%
Millicom International Cellular SA
XERS5.02-0.15
-2.90%
Xeris Biopharma Holdings

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AMRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
-2.81%
AMRX - HROW
46%
Loosely correlated
+0.75%
EBS - HROW
39%
Loosely correlated
-4.02%
OGI - HROW
34%
Loosely correlated
+1.32%
AMPH - HROW
32%
Poorly correlated
-1.15%
VTRS - HROW
31%
Poorly correlated
+0.64%
More

TLPH and

Correlation & Price change

A.I.dvisor tells us that TLPH and LVZPF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPH and LVZPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPH
1D Price
Change %
TLPH100%
-1.21%
LVZPF - TLPH
31%
Poorly correlated
N/A
TXMD - TLPH
25%
Poorly correlated
+4.39%
HROW - TLPH
22%
Poorly correlated
-2.81%
RDY - TLPH
22%
Poorly correlated
+0.36%
OILFF - TLPH
20%
Poorly correlated
-2.09%
More